RankAlpha logo
Back to Rankings

SPRY

ARSB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
SPRY vs peer average
71/100
SPRY vs. peer average (B vs. C)
Grade spread
A 2 · B 1 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMPH is the first available peer comparator.

Same-sector small-cap pharma peer with a similarly sized market cap; useful as a read-through on specialty-drug execution and payer/access dynamics, though not a clean epinephrine analog.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAMPHAmphastar
SPRY
ARS
AMPH
Amphastar
Grade
B
D
Momentum
29
8
Value
43
71
Sentiment
100
65
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs AMPH

SPRY / AMPH
Grade Position
Above peers
SPRY vs. peer average (B vs. C)
71/100
Momentum
29
SPRY
Value
43
AMPH
Sentiment
100
SPRY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SPRY
1
AMPH
AMPH
B
80/100
Even
2
DRUG
DRUG
C
60/100
+1
3
ABUS
Arbutus Biopharma Corp Common
C
60/100
+1
4
KURA
Kura Oncology Inc Common
A
100/100
-1
5
JANX
Janux Therapeutics Inc Common
D
40/100
+2
AMPH is the first peer returned for this comparison set.